Looking Towards the Future of HR+/HER2- Breast Cancer

Posted by & filed under Uncategorized.

Exciting Advances in Endocrine Therapies for Breast Cancer! 🌟 In a recent OncLive Peer Exchange, our very own Dr. Gregory Vidal shares a panel with Dr. Komal Jhaveri, Dr. Timothy Pluard, Dr. Aditya Bardia, and Dr. VK Gadi to discuss the promising landscape of novel endocrine drugs. Discussion highlights include: – The emergence of selective… Read more »

Best of ASCO – Memphis Conference

Posted by & filed under Uncategorized.

This past weekend, Drs. Bradley Somer, Gregory Vidal, and Jason Porter hosted presentations at the Best of ASCO – Memphis Conference! This Post ASCO review showcased abstracts from highly rated presentations and the latest research in oncology education. Our physicians helped lead several discussions including: Dr. Jason Porter: – “Personalizing Treatment for Adult Patients with… Read more »

Man2Man Prostate Event | 9.23.23

Posted by & filed under Uncategorized.

Join us at the Man2Man Prostate Cancer Group’s free event to raise awareness about prostate cancer! Enjoy a lineup of expert speakers, free PSA and health screenings, live entertainment, and life-changing cancer information. When: Saturday, September 23, 2023, from 10:00 AM to 1:00 PM Where: West Cancer Center – 7945 Wolf River Blvd, Germantown, TN… Read more »

West Oncology Conference for Advanced Providers and Nurses

Posted by & filed under Uncategorized.

Join us for this year’s West Oncology Conference for Advanced Practitioners and Nurses! 📆 Friday, October 6, 2023 ⏱ 8am – 3pm 📍 Online Event This virtual program is designed to provide insights into the latest developments in multidisciplinary treatment, practical patient management, and inter-professional care. This interactive event aims to enhance communication within the… Read more »

The Best of ASCO – Memphis

Posted by & filed under Uncategorized.

West Medical Oncologists, Dr. Bradley Somer and Dr. Gregory Vidal are two of the presenters for the upcoming Best of ASCO – Memphis Conference. Dr. Vidal will host two sessions: the SEEK Workshop Primer Panel and Diversity in Cancer Care, while Dr. Somer will host a session on GU Cancers. This Post ASCO Review will… Read more »

Key Risk Factors Affecting Treatment Choice in Melanoma with Dr. G. Gary Tian

Posted by & filed under Uncategorized.

Key Risk Factors Affecting Treatment Choice in Melanoma   West provider, Dr. G. Gary Tian, joins Dr. Evan J. Lipson with John Hopkins Medicine and other oncology experts to discuss critical factors influencing physicians’ decisions between monotherapy and doublet therapy for Metastatic Melanoma.   The group dives into the latest treatment options for metastatic melanoma,… Read more »

Standard-of-Care Treatment Approaches for HR+/HER2 Early Breast Cancer ft. Dr. Gregory Vidal

Posted by & filed under Uncategorized.

In a recent OncLive Peer Exchange, Dr. Gregory Vidal partnered with a panel of breast oncology experts to discuss the standard-of-care treatment approaches for early-stage HR-positive/HER2-negative breast cancer.   Topics include: – Evolution of HER2-negative management – Updates in HR-positive treatment – Importance of genetic testing – Utilization of endocrine therapy – BRCA mutations and… Read more »

Meet Judy: Esophageal Cancer Survivor

Posted by & filed under Uncategorized.

Meet Judy: Esophageal Cancer Survivor   Judy came to our West family after she and her husband moved from Florida to Memphis post-retirement. While in Florida, Judy was at high risk for developing esophageal cancer and received frequent screenings to ensure early detection. She was ultimately diagnosed with Stage IV esophageal cancer and would have… Read more »

Updates in GI Cancers with Dr. Axel Grothey

Posted by & filed under Uncategorized.

Exciting updates in GI Cancers! Dr. Axel Grothey from West Cancer Center shared groundbreaking insights at the Total Health Spring Oncology Review and Renew Conference. He highlighted major advancements in targeted therapies and precision medicine for GI cancers. Here are the key highlights: Gastro-Esophageal Junction (GEJ) Cancers: Dr. Grothey revealed a new biomarker, Claudin 18.2… Read more »